Human Upper Extremity Allotransplantation: F/U Protocol
Trial Summary
What is the purpose of this trial?
Upper extremity allotransplantation is a new procedure which is becoming more common in the United States. Ongoing data collection for research purposes is vital to the long-term assessment as to the safety of the procedure and accompanying immunosuppression protocol, as well as quantifying patient outcomes and changes in quality of life. For these reasons, The Johns Hopkins Hand/Arm Transplantation Team is interested in enrolling transplanted patients in a follow-up protocol to continue collecting informative data to further the field of vascularized composite allotransplantation.
Research Team
Jaimie Shores, M.D.
Principal Investigator
Johns Hopkins University
Eligibility Criteria
Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo upper extremity allotransplantation and receive immunosuppression protocol
Follow-up
Participants are monitored for safety, effectiveness, and quality of life post-transplantation
Long-term follow-up
Ongoing data collection for research purposes to assess long-term safety and outcomes
Treatment Details
Interventions
- Upper Extremity Allotransplantation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor